Celldex Therapeutics, Inc. (CLDX) Shareholder Equity
- 2026-06-30: Common Stock, Value, IssuedUSD $79.00K; Additional Paid in Capital, Common StockUSD $2.68B; Accumulated Other Comprehensive Income (Loss), Foreign Currency Translation Adjustment, Net of TaxUSD (m); Accumulated Other Comprehensive Income (Loss), Net of TaxUSD $1.30M.
- 2026-03-31: Common Stock, Value, IssuedUSD $67.00K; Additional Paid in Capital, Common StockUSD $2.35B; Accumulated Other Comprehensive Income (Loss), Foreign Currency Translation Adjustment, Net of TaxUSD (m); Accumulated Other Comprehensive Income (Loss), Net of TaxUSD $2.52M.
- 2025-12-31: Common Stock, Value, IssuedUSD $67.00K; Additional Paid in Capital, Common StockUSD $2.34B; Accumulated Other Comprehensive Income (Loss), Foreign Currency Translation Adjustment, Net of TaxUSD $2.60M; Accumulated Other Comprehensive Income (Loss), Net of TaxUSD $3.63M.
- 2025-09-30: Common Stock, Value, IssuedUSD $66.00K; Additional Paid in Capital, Common StockUSD $2.33B; Accumulated Other Comprehensive Income (Loss), Foreign Currency Translation Adjustment, Net of TaxUSD (m); Accumulated Other Comprehensive Income (Loss), Net of TaxUSD $3.77M.
Celldex Therapeutics, Inc. Shareholder Equity
Filed components and totals, with each concept and unit kept separate. Components can overlap; they are not added together. Missing disclosures remain (m). Original concept pages retain their detailed breakdowns and history.
| Period end | Common Stock, Value, Issued USD | Additional Paid in Capital, Common Stock USD | Accumulated Other Comprehensive Income (Loss), Foreign Currency Translation Adjustment, Net of Tax USD | Accumulated Other Comprehensive Income (Loss), Net of Tax USD | Retained Earnings (Accumulated Deficit) USD | Stockholders' Equity Attributable to Parent USD | APIC, Share-based Payment Arrangement, Increase for Cost Recognition USD | Reclassification from Accumulated Other Comprehensive Income, Current Period, Net of Tax USD | Preferred Stock, Value, Issued USD | Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest USD |
|---|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $79.00K | $2.68B | (m) | $1.30M | $-1.97B | $714.56M | 3 month · $8.41M | 6 month · $0.00 | (m) | (m) |
| 2026-03-31 | $67.00K | $2.35B | (m) | $2.52M | $-1.89B | $456.23M | 3 month · $8.52M | 3 month · $0.00 | (m) | (m) |
| 2025-12-31 | $67.00K | $2.34B | $2.60M | $3.63M | $-1.81B | $527.16M | 12 month · $36.22M | 12 month · $0.00 | (m) | (m) |
| 2025-09-30 | $66.00K | $2.33B | (m) | $3.77M | $-1.73B | $598.36M | 3 month · $8.80M | 9 month · $0.00 | (m) | (m) |
| 2025-06-30 | $66.00K | $2.32B | (m) | $3.34M | $-1.67B | $655.41M | 3 month · $9.19M | 6 month · $0.00 | (m) | (m) |
| 2025-03-31 | $66.00K | $2.31B | (m) | $3.57M | $-1.61B | $702.98M | 3 month · $9.32M | 3 month · $0.00 | (m) | (m) |
| 2024-12-31 | $66.00K | $2.30B | $2.60M | $3.31M | $-1.56B | $747.00M | 12 month · $34.24M | 12 month · $0.00 | (m) | (m) |
| 2024-09-30 | $66.00K | $2.29B | (m) | $5.29M | $-1.51B | $785.90M | 3 month · $9.62M | 9 month · $0.00 | (m) | (m) |
| 2024-06-30 | $66.00K | $2.28B | (m) | $1.78M | $-1.47B | $813.66M | 3 month · $7.64M | 6 month · $0.00 | (m) | (m) |
| 2024-03-31 | $66.00K | $2.27B | (m) | $2.24M | $-1.43B | $838.61M | 3 month · $7.20M | 3 month · $0.00 | (m) | (m) |
| 2023-12-31 | $56.00K | $1.82B | $2.60M | $3.31M | $-1.40B | $429.17M | 12 month · $23.89M | 12 month · $0.00 | (m) | (m) |
| 2023-09-30 | $47.00K | $1.60B | (m) | $2.13M | $-1.35B | $246.72M | 3 month · $7.12M | 9 month · $0.00 | (m) | (m) |
| 2023-06-30 | $47.00K | $1.59B | (m) | $2.07M | $-1.32B | $277.54M | 3 month · $5.22M | 6 month · $0.00 | (m) | (m) |
| 2023-03-31 | $47.00K | $1.59B | (m) | $2.12M | $-1.29B | $302.74M | 3 month · $4.34M | 3 month · $0.00 | (m) | (m) |
| 2022-12-31 | $47.00K | $1.58B | $2.60M | $1.26M | $-1.26B | $326.20M | 12 month · $15.61M | 12 month · $0.00 | $0.00 | (m) |
| 2022-09-30 | $47.00K | $1.57B | (m) | $-112.00K | $-1.23B | $345.42M | 3 month · $4.50M | 9 month · $0.00 | (m) | (m) |
| 2022-06-30 | $47.00K | $1.57B | (m) | $-417.00K | $-1.20B | $365.09M | 3 month · $3.45M | 6 month · $0.00 | (m) | (m) |
| 2022-03-31 | $47.00K | $1.56B | (m) | $112.00K | $-1.17B | $398.10M | 3 month · $3.15M | 3 month · $0.00 | (m) | (m) |
| 2021-12-31 | $47.00K | $1.56B | $2.60M | $1.89M | $-1.14B | $419.48M | 12 month · $8.95M | 12 month · $0.00 | $0.00 | (m) |
| 2021-09-30 | $47.00K | $1.56B | (m) | $2.55M | $-1.12B | $436.71M | 3 month · $3.03M | 9 month · $0.00 | (m) | (m) |
| 2021-06-30 | $40.00K | $1.28B | (m) | $2.59M | $-1.10B | $182.28M | 3 month · $1.51M | 6 month · $0.00 | (m) | (m) |
| 2021-03-31 | $40.00K | $1.28B | (m) | $2.59M | $-1.09B | $194.17M | 3 month · $1.27M | 3 month · $0.00 | (m) | (m) |
| 2020-12-31 | $40.00K | $1.28B | $2.60M | $2.59M | $-1.07B | $209.36M | 12 month · $3.92M | 12 month · $0.00 | (m) | (m) |
| 2020-09-30 | $40.00K | $1.28B | (m) | $2.61M | $-1.05B | $229.97M | 3 month · $1.25M | 9 month · $0.00 | (m) | (m) |
| 2020-06-30 | $39.00K | $1.27B | (m) | $2.59M | $-1.04B | $238.44M | 3 month · $722.00K | 6 month · $0.00 | (m) | (m) |
| 2020-03-31 | $18.00K | $1.11B | (m) | $2.60M | $-1.03B | $83.70M | 3 month · $686.00K | 3 month · $0.00 | (m) | (m) |
| 2019-12-31 | $17.00K | $1.10B | $2.60M | $2.62M | $-1.01B | $94.03M | 12 month · $4.55M | 12 month · $0.00 | (m) | (m) |
| 2019-09-30 | $16.00K | $1.10B | (m) | $2.63M | $-1.00B | $101.38M | 3 month · $707.00K | 9 month · $0.00 | (m) | (m) |
| 2019-06-30 | $15.00K | $1.10B | (m) | $2.64M | $-991.46M | $109.63M | 3 month · $1.46M | 6 month · $0.00 | (m) | (m) |
| 2019-03-31 | $13.00K | $1.09B | (m) | $2.60M | $-979.68M | $112.69M | 3 month · $1.69M | 3 month · $0.00 | (m) | (m) |
| 2018-12-31 | $12.00K | $1.08B | $2.60M | $2.58M | $-962.44M | $124.06M | 12 month · $8.08M | 12 month · $0.00 | (m) | (m) |
| 2018-09-30 | $169.00K | $1.08B | (m) | $2.58M | $-953.04M | $128.13M | 3 month · $1.79M | 9 month · $0.00 | (m) | (m) |
| 2018-06-30 | $157.00K | $1.07B | (m) | $2.59M | $-945.79M | $128.05M | 3 month · $2.05M | 6 month · $0.00 | (m) | (m) |
| 2018-03-31 | $143.00K | $1.06B | (m) | $2.56M | $-929.39M | $134.09M | 3 month · $2.49M | 3 month · $0.00 | (m) | (m) |
| 2017-12-31 | $9.00K | $1.05B | $2.60M | $2.56M | $-812.52M | $236.37M | 12 month · $12.31M | 12 month · $0.00 | (m) | (m) |
| 2017-09-30 | $132.00K | $1.03B | (m) | $2.59M | $-808.68M | $219.15M | (m) | 9 month · $0.00 | (m) | (m) |
| 2017-06-30 | $127.00K | $1.01B | (m) | $2.58M | $-782.31M | $231.46M | (m) | 6 month · $0.00 | (m) | (m) |
| 2017-03-31 | $124.00K | $998.90M | (m) | $2.56M | $-753.75M | $247.84M | (m) | (m) | (m) | (m) |
| 2016-12-31 | $121.00K | $982.25M | $2.60M | $2.54M | $-719.49M | $265.43M | 12 month · $15.32M | 12 month · $0.00 | (m) | (m) |
| 2016-09-30 | $101.00K | $901.56M | (m) | $2.61M | $-687.18M | $217.09M | (m) | (m) | (m) | (m) |
| 2016-06-30 | $99.00K | $889.47M | (m) | $2.72M | $-657.58M | $234.71M | (m) | (m) | (m) | (m) |
| 2016-03-31 | $99.00K | $882.88M | (m) | $2.69M | $-625.63M | $260.03M | (m) | (m) | (m) | (m) |
| 2015-12-31 | $99.00K | $878.65M | $2.60M | $2.31M | $-590.96M | $290.11M | 12 month · $12.77M | 12 month · $0.00 | (m) | (m) |
| 2015-09-30 | $99.00K | $874.24M | (m) | $2.56M | $-558.27M | $318.63M | (m) | (m) | (m) | (m) |
| 2015-06-30 | $99.00K | $869.63M | (m) | $2.44M | $-526.29M | $345.88M | (m) | (m) | (m) | (m) |
| 2015-03-31 | $98.00K | $866.77M | (m) | $2.62M | $-493.93M | $375.55M | (m) | 3 month · $0.00 | (m) | (m) |
| 2014-12-31 | $90.00K | $672.74M | $2.60M | $2.59M | $-463.76M | $211.66M | 12 month · $6.85M | 12 month · $0.00 | (m) | (m) |
| 2014-09-30 | $89.00K | $668.60M | (m) | $2.62M | $-431.94M | $239.37M | (m) | 3 month · $0.00 9 month · $0.00 | (m) | (m) |
| 2014-06-30 | $89.00K | $666.33M | (m) | $2.75M | $-403.86M | $265.31M | (m) | 3 month · $0.00 6 month · $0.00 | (m) | (m) |
| 2014-03-31 | $89.00K | $664.67M | (m) | $2.67M | $-375.58M | $291.85M | (m) | 3 month · $0.00 | (m) | (m) |
| 2013-12-31 | $89.00K | $662.72M | $2.60M | $2.67M | $-345.68M | $319.80M | 12 month · $4.55M | 12 month · $0.00 | (m) | (m) |
| 2013-09-30 | $81.00K | $477.60M | (m) | $2.69M | $-323.62M | $156.75M | (m) | 3 month · $0.00 9 month · $0.00 | (m) | (m) |
| 2013-06-30 | $81.00K | $474.94M | (m) | $2.55M | $-300.48M | $177.09M | (m) | (m) | (m) | (m) |
| 2013-03-31 | $81.00K | $473.63M | (m) | $2.69M | $-281.46M | $194.94M | (m) | 3 month · $0.00 | (m) | (m) |
| 2012-12-31 | $64.00K | $357.09M | $2.60M | $2.75M | $-264.13M | $95.77M | 12 month · $2.30M | 12 month · $0.00 | (m) | (m) |
| 2012-09-30 | $61.00K | $335.50M | (m) | $2.77M | $-247.32M | $91.02M | (m) | (m) | (m) | (m) |
| 2012-06-30 | $59.00K | $324.06M | (m) | $2.72M | $-232.29M | $94.55M | (m) | (m) | (m) | (m) |
| 2012-03-31 | $59.00K | $323.59M | (m) | $2.76M | $-218.52M | $107.89M | (m) | (m) | (m) | (m) |
| 2011-12-31 | $44.00K | $271.03M | $2.60M | $2.65M | $-205.01M | $68.72M | 12 month · $2.34M | 12 month · $0.00 | (m) | (m) |
| 2011-09-30 | $44.00K | $270.25M | (m) | $2.65M | $-192.27M | $80.67M | (m) | (m) | (m) | (m) |
| 2011-06-30 | $44.00K | $269.69M | (m) | $2.77M | $-180.50M | (m) | (m) | (m) | (m) | $92.00M |
| 2010-12-31 | $32.00K | $232.68M | (m) | $2.75M | $-160.21M | $75.25M | 12 month · $2.80M | (m) | (m) | $75.25M |
| 2009-12-31 | (m) | (m) | (m) | (m) | (m) | $73.77M | 12 month · $3.06M | (m) | (m) | (m) |
| 2008-12-31 | (m) | (m) | (m) | (m) | (m) | $18.13M | (m) | (m) | (m) | (m) |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NEOGEN CORP (NEOG) | United States | $2.979B | -247.49 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |